$SHMN~5 New Products, NO R/S, Share Buyback, Low Float~DD
~~~~ NEW STRATEGIC PARTNERSHIP~~~
Sohm is in an advanced negotiating stage with a pharmaceutical distribution company for manufacturing and supplying a line of Prescription and OTC products. Once this agreement is consummated, SOHM anticipates a significant increase in its revenues in 2021 and the foreseeable future. We look forward to this collaboration and will continue to update our investors as we progress with this strategic partnership.
1) $SHMN~ SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as a strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals were exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia. To know more about SOHM, Inc., visit
The Company’s strategic manufacturing facility enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution.
The following table lists the NDC drug codes by SOHM Inc.: NDC Trade Name Labeler Name
50405-0016 Hand Sanitizer SOHM Inc 50405-0110 Salic-2 SOHM Inc. 50405-0002 SohMed Acid Reducer SOHM Inc. 50405-0005 SohMed Alertness Aid SOHM Inc. 50405-0004 SohMed Allergy SOHM Inc. 50405-0003 SohMed Allergy Sinus SOHM Inc. 50405-0006 SohMed Cold Relief SOHM Inc. 50405-0001 SohMed Extra Strength SOHM Inc. 50405-0007 SohMed Pain Relief PM SOHM Inc. 50405-0008 SohMed Pain Reliever SOHM Inc. 50405-0009 SohMed Sinus Sohm Inc.
5) September 11, 2020 News: The company has continued with the development and introduction of 5 new products into its product line while maintaining consistency with the company’s outlook and strategic plan. All manufacturing is in the USA. Our products are currently being marketed and sold in the USA.
$SHMN 1. Nail Renovar-Nail Fungus treatment. This global market is projected to reach 6.7 Billion by 2026.
6) $SHMN~ 20,000 sq ft. FDA certified Sought California Facility
CEO Baron Night: “Our manufacturing alliance partner operates a 20,000 square ft. Southern California facility that is FDA certified and OTC and Prescription (Rx) drug and cGMP compliant. They specialize in product development and the manufacture of skin, hair, and body care products as well as color cosmetics. This manufacturing house not only has over 4500 formulas available and accessible to us but, has the capability to modify these formulas to suit our as well as our client’s needs.”
September 11, 2020 NEWS: The company has not issued any shares to anyone including promoters, officers, directors, and/or employees in the last several years.
(i) Name: Swati Shah; 5% or more shareholder (ii) Business Address: 7889 Garden Park St., Chino, CA 91708 (iii) Number and Class of Shares Beneficially Owned: 96,180,086 common shares (iv) Shares are restricted pursuant to Rule 144 (v) Acquired shares for services rendered
(i) Name: BHAT Family Trust., 5% or more shareholder (ii) Business Address: 6920 Knott Ave., Suite C, Buena Park, CA 90621 (iii) Number and Class of Shares Beneficially Owned: 82,000,000 Common Shares (iv) Shares do not bear the restricted legend (v) Shares acquired through an investment company
The management is not intending to conduct any reverse split but in coming days/weeks and months, the company will be considering a share buyback program.
10) $SHMN has 154 million SHARE BUYBACK until February 28, 2021
The buyback program as currently planned will take place between March 1, 2019 and February 28, 2021, with an initial target of 10% of the current outstanding shares of SOHM, Inc. common stock (approximately 154,000,000 shares), with not less than 50% to be retired. Pursuant to the safe harbor provisions of Rule 10b-18, these shares will be acquired by SOHM on the public market, and will be subject to the manner of purchase, timing, price, and volume restrictions specified therein.
$SHMN CEO Baron Night is an expert In financial sector for more than 40 years in different industries, SOHM looking forward to getting the expertise of him
Chino Hills, CA – September 11, 2020 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, ...
$SOHM, INC., ANNOUNCES SHARES BUYBACK PROGRAM
02/26/2019 posted in Press Releases
Chino Hills, CA – February 26, 2019 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, ...
News 
Market Data 
Discover 
.png)
